The Long, Winding Road to Precision Medicine in AML

It is now almost six years since Drs Sekeres and Steensma ruefully described acute myeloid leukaemia (AML) as “the Boulevard of Broken Dreams”, reflecting the catalogue of failed attempts to develop novel treatments for this intractable disease. While the treatment of many other cancers has been transformed by targeted medicines, AML has stubbornly refused to yield, […]

Read More…